An informal round table discussion on the role of the Oncotype DX Breast Recurrence Score® test.
Genomic Health like to invite you to attend an informal round table discussion to meet with David Hyams, M.D. F.A.C.S., Eisenhower Medical Centre, Southern California and to discuss the role of the Oncotype DX Breast Recurrence Score® test, how it is used within breast cancer services in the USA and its role in helping to ensure optimal treatment for patients with early stage breast cancer.
The meeting will be held at the Macdonald Holyrood Hotel from 2 to 4 pm, on Monday 28 October 2019 and will be facilitated by Andrew Strong, Assistant Director of Policy and Communications, the Health and Social Care Alliance Scotland (the ALLIANCE). Afternoon tea will be available.
Areas of Discussion
- Dr Hyams perspective on the value of the Oncotype DX® test; its origins and impact, a review of the latest published evidence and guidelines.
- Facilitated by Andrew Strong,
- In NHS Scotland, how is the realistic medicine vision being translated into clinical & service settings? What are the key considerations and does the Oncotype DX test offer added value in this context?
- What information regarding the test would patients find useful and how can that best be delivered?
We hope you will be able to join us for the meeting for an interesting and important discussion. Further details will be available in due course.
This meeting is fully sponsored by Genomic Health UK Ltd.
|Location:||Macdonald Holyrood Hotel|
For more details contact
|Phone number:||020 3998 3233|